[Featured Stock] Bridge Biotherapeutics Surges on No-Dilution Announcement

[Asia Economy Reporter Minji Lee] Bridge Biotherapeutics surged sharply following news of its decision to conduct a free capital increase.

At 11:09 AM on the 8th, Bridge Biotherapeutics was trading at 42,450 KRW, up 26.53% from the previous session. On the same day, the company announced that it had decided to allocate 2 new shares for every 1 common share through a free capital increase.

The new shares amount to 12,774,116 common shares, bringing the total number of issued shares to 19,161,174 after the free capital increase.

The record date for the new share allocation is the 23rd of this month. The scheduled listing date is the 15th of next month.